Correlation Between Salarius Pharmaceuticals and Orchard Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Orchard Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Orchard Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Orchard Therapeutics PLC, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Orchard Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Orchard Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Orchard Therapeutics.
Diversification Opportunities for Salarius Pharmaceuticals and Orchard Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Salarius and Orchard is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Orchard Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchard Therapeutics PLC and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Orchard Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchard Therapeutics PLC has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Orchard Therapeutics go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and Orchard Therapeutics
Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to under-perform the Orchard Therapeutics. In addition to that, Salarius Pharmaceuticals is 3.07 times more volatile than Orchard Therapeutics PLC. It trades about -0.04 of its total potential returns per unit of risk. Orchard Therapeutics PLC is currently generating about 0.08 per unit of volatility. If you would invest 497.00 in Orchard Therapeutics PLC on August 31, 2024 and sell it today you would earn a total of 30.00 from holding Orchard Therapeutics PLC or generate 6.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Salarius Pharmaceuticals vs. Orchard Therapeutics PLC
Performance |
| Timeline |
| Salarius Pharmaceuticals |
| Orchard Therapeutics PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Salarius Pharmaceuticals and Orchard Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salarius Pharmaceuticals and Orchard Therapeutics
The main advantage of trading using opposite Salarius Pharmaceuticals and Orchard Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Orchard Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchard Therapeutics will offset losses from the drop in Orchard Therapeutics' long position.| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
| Orchard Therapeutics vs. X4 Pharmaceuticals | Orchard Therapeutics vs. Terns Pharmaceuticals | Orchard Therapeutics vs. Day One Biopharmaceuticals | Orchard Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |